United Therapeutics Corporation · NASDAQ:UTHR

Edgemond James sold 10,000 United Therapeutics Corporation shares (Form 4)

Traded May 7, 2026 · Filed May 11, 2026

On May 7, 2026, Edgemond James (CFO AND TREASURER) sold 10,000 United Therapeutics Corporation shares at an average US$578.58 for US$5.79M under a trading plan, leaving 18,876 shares. Filed May 11, 2026 (Form 4).

Sold
10,000 shares
Price
US$578.58 average (US$569.71 to US$597.54)
Value
US$5.79M
Holding after
18,876 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CFO AND TREASURER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 7, 2026Common StockOption exercise10,000US$135.4228,876Direct
May 7, 2026Common StockSale560US$569.7128,316Direct
May 7, 2026Common StockSale560US$571.7727,756Direct
May 7, 2026Common StockSale807US$572.9326,949Direct
May 7, 2026Common StockSale1,306US$573.9425,643Direct
May 7, 2026Common StockSale1,045US$575.1424,598Direct
May 7, 2026Common StockSale1,002US$575.9823,596Direct
May 7, 2026Common StockSale640US$577.4222,956Direct
May 7, 2026Common StockSale520US$578.6522,436Direct
May 7, 2026Common StockSale399US$580.3722,037Direct
May 7, 2026Common StockSale281US$581.5021,756Direct
May 7, 2026Common StockSale200US$583.4121,556Direct
May 7, 2026Common StockSale400US$584.2121,156Direct
May 7, 2026Common StockSale640US$585.8320,516Direct
May 7, 2026Common StockSale340US$586.7320,176Direct
May 7, 2026Common StockSale700US$587.7419,476Direct
May 7, 2026Common StockSale320US$589.0219,156Direct
May 7, 2026Common StockSale120US$589.7219,036Direct
May 7, 2026Common StockSale160US$597.5418,876Direct

Source

View original at SEC

Related